Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

N-acetyl-cysteine shows promise in treating various diseases and may improve skin and hair conditions, but more research is needed on dosages and long-term effects.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

Oral minoxidil is as effective and safe as topical minoxidil for treating female pattern hair loss.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Hormonal therapy is becoming a promising treatment for acne.

Finasteride may help improve certain brain function issues linked to dopamine.

Hair loss can be a side effect of certain blood thinners.

Methotrexate plus prednisolone had the fewest serious side effects.

Finasteride reduces hair growth in women with hirsutism and works better with electrolysis.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

Spironolactone is a promising alternative to antibiotics for treating acne in adult females.

Acne treatment, including isotretinoin, improves quality of life and does not worsen depression.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Lowering 3α,5α-THP in the hippocampus increases anxiety and depression in proestrous rats.

Stopping the beta-blocker nadolol led to quick hair regrowth and improved scalp condition.

ENERGI-F701 solution was found to be more effective and safer than Regaine® 2% minoxidil solution in treating female pattern hair loss, with increased hair density and less side effects.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

Some medicines can reduce excessive hair growth in women, but more research is needed to compare treatments and consider side effects.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

A woman got a scalp condition from using latanoprost, but it improved after stopping the drug and starting other treatments.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.